Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: September 19, 2024
Subject: Announcement of financial results for the three months and full fiscal year ended June 30, 2024.
Context: The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, NY. This filing serves to distribute a press release (Exhibit 99.1) containing the detailed financial results.
Key Financial Metrics
The provided Form 8-K text acts as a cover document referencing a press release (Exhibit 99.1) for specific data. The filing text itself does not provide clear values for the following metrics:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Investors must refer to the attached press release (Exhibit 99.1) for these specific figures.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. It only confirms that results for the period ended June 30, 2024, have been announced.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing text does not contain forward-looking guidance or management commentary regarding future performance.
Risks and Contingencies: No specific risks or contingencies are detailed in this 8-K text. The document includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the specific revenue and net loss figures in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K body.
- Confirm the Company's cash runway and liquidity status as of June 30, 2024, given the lack of data in this summary filing.
- Review the press release for any updates on the Company's core business operations or strategic initiatives.
- Note that the Company is classified as an "Emerging Growth Company" under Rule 405 of the Securities Act of 1933.